Hypromellose Eye Drops Bpc 0.3%
SUMMARY OF PRODUCT CHARACTERISTICS
1 NAME OF THE MEDICINAL PRODUCT
Hypromellose Eye Drops BPC 0.3%
2 QUALITATIVE AND QUANTITATIVE COMPOSITION
Hypromellose BP (4500)
3 PHARMACEUTICAL FORM
Eye drops
4 CLINICAL PARTICULARS
4.1 Therapeutic indications
To provide tear-like lubrication for the symptomatic relief of dry eyes and eye irritation associated with deficient tear production.
As an ocular lubricant for artificial eyes.
4.2. Posology and Method of Administration
Adults, children and the elderly
The dose depends on the need for lubrication. Usually one or two drops to each eye three times daily or as prescribed.
4.3 Contraindications
Hypersensitivity to any component.
Contains benzalkonium chloride, soft contact should not be worn.
4.4 Special warnings and special precautions for use
If irritation persists or worsens, or headache, eye pain, vision changes or continuous redness occur, discontinue use and consult a physician.
Pharmacogenetic problems None known.
4.5. Interactions with other Medicinal Products and other Forms of Interaction
None known.
4.6. Pregnancy and Lactation
There is insufficient evidence of safety in pregnancy and this product should, therefore, only be used in pregnancy if it is considered essential by the physician.
4.7. Effects on Ability to Drive and Use Machines
May cause transient mild stinging or temporary blurring of vision. Do not drive or operate machinery unless vision is clear.
4.8. Undesirable Effects
May cause transient mild stinging or temporary blurring of vision.
4.9 Overdose
Not applicable.
5 PHARMACOLOGICAL PROPERTIES
5.1 Pharmacodynamic properties
This product is a sterile, isotonic, buffered solution of Hypromellose. It is used as a substitute for natural tears.
5.2. Pharmacokinetic Properties
Not appropriate.
5.3 Preclinical safety data
None stated.
6 PHARMACEUTICAL PARTICULARS
6.1 List of excipients
Purified water, Sodium Chloride, Potassium Chloride, Borax, Boric Acid, Benzalkonium Chloride solution and may contain sodium hydroxide or hydrochloric acid.
6.2. Incompatibilities
None known.
6.3. Shelf-Life
36 months unopened.
28 days after opening.
6.4. Special Precautions for Storage
Store below 25°C.
6.5. Nature and Content of Container
Plastic tamper evident eye drop assembly. Fill volume 10ml.
6.6. Instructions for Use, Handling and Disposal
None stated.
ADMINISTRATION DETAILS
7 MARKETING AUTHORISATION HOLDER
Martindale Pharmaceuticals Ltd
Bampton Road
Romford
RM3 8UG
England.
8 MARKETING AUTHORISATION NUMBER(S)
PL 00156/0069
9 DATE OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION
06/06/1997
10 DATE OF REVISION OF THE TEXT
27/03/2002